Medicine guide
M-M-RVaxPro
·
- Prescription status not stated
- Antibiotics, antivirals and antifungals taken into the body
- Active substance
- Measles, mumps and rubella vaccine (live)
- Made by
- Merck Sharp & Dohme B.V.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- M-M-RVaxPro is indicated for simultaneous vaccination against measles, mumps, and rubella in individuals 12 months or older. For use in measles outbreaks, or for post-exposure vaccination, or for use in previously unvaccinated children older than 12 months who are in contact with susceptible pregnant women, and persons likely to be susceptible to mumps and rubella.
From the official label · 2026-09-30 · European Medicines Agency
Details
| Made by | Merck Sharp & Dohme B.V. |
|---|---|
| Active substance | Measles, mumps and rubella vaccine (live) |
| Used in | Antibiotics, antivirals and antifungals taken into the body |
| Classification | J07BD52 · Antibiotics, antivirals and antifungals taken into the body |
| Authorised on | 2006-05-05 |
| Last updated by the regulator | 2025-10-30 |
| EMA product number | EMEA/H/C/000604 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).